MedTrace Logo

Treatment Patterns, Outcomes and Testing in EGFRm NSCLC Patients With EGFR TKI 1L Across Europe (REFLECT)

NCT04031898 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 896

Last updated 2020-12-23

No results posted yet for this study

Summary

Multinational, multi-center medical record review to describe the treatment patterns, clinical outcomes, and EGFR / T790M testing practices in EGFR-mutated advanced NSCLC patients receiving first-line EGFR TKI therapy in Europe.

Conditions

Interventions

OTHER

Non Interventional

This is a non interventional, observational, retrospective study including patients with EGFR-mutated advanced NSCLC, treated with 1st or 2nd generation EGFR TKI therapy in first line

Sponsors & Collaborators

Principal Investigators

  • Konstantinos Syrigos, Prof. · Oncology Unit, Athens University School of Medicine,

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-07
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • Bulgaria

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04031898 on ClinicalTrials.gov